ASH 2012 Interview with Dr. Rick Furman - CLL Support

CLL Support

22,990 members39,474 posts

ASH 2012 Interview with Dr. Rick Furman

bkoffman profile image
bkoffmanCLL CURE Hero
3 Replies

This is one of my favorite interviews as it tells the story of the phase 1 trials of ibrutinib and idelalisib (CAL 101) by Dr. Furman who was the investigator for them both. See bkoffman.blogspot.com

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
3 Replies
Mikey47 profile image
Mikey47

Hi Brian,

Thanks for that.

Liked the Leonard Cohen at the IOW :) I saw him at the O2 centre in London a few years ago. He still has 'it' and it was a great show. Many other musicians there, including David Gilmour from Pink Floyd.

jangreen profile image
jangreen

Hi Its interesting to hear how important it is to listen to patients and their views when trying new drugs.

bkoffman profile image
bkoffmanCLL CURE Hero

@jangreen. Agreed. We all learn from each other.

Not what you're looking for?

You may also like...

ASH 2013: INTERVIEW WITH DR. FURMAN RE: IDELALISIB

Hi friends In my last blog post ( http://bkoffman.blogspot.com ), I have a short and interesting...

ASH 2012 Interview: Dr Jeff Sharman "Why New CLL Treatments Supersede FCR"

Dr Sharman's blog http://www.cll-nhl.com, is well worth keeping an eye on for pertinent but easily...

ASH 2012 Ibrutinib Press Conference

Patient Power Video...

COVID-19 Vaccinations & Testing Dr. Furman & LLS

We had a CLL Society Zoom session on vaccinations with Dr. Furman April 11. He discourages getting...

Dr. Furman on the Diminishing Role of FCR

Hi, As we're getting ready to head to ASH this week, we wanted to post in response to a query that...